Serum level of prostate-specific antigen (PSA) in women with breast cancer
Authors:
- Fawzi C. MashkoorFawzi C. Mashkoor
- Jasim N. Al-AsadiJasim N. Al-Asadi
- Lamia M. Al-NaamaLALamia M. Al-Naama
- 1 October 2013
- journal article
- Published by Elsevier in Cancer Epidemiology
- Vol. 37 (5) , 613-618
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Breast Cancer in Developing Countries: Opportunities for Improved SurvivalJournal of Oncology, 2010
- The first national public breast cancer screening program in Saudi ArabiaAnnals of Saudi Medicine, 2010
- FIVE YEAR SURVIVAL IN PATIENTS WITH BREAST CANCER A STUDY CARRIED AT THE ONCOLOGY CENTER OF BASRAHThe Medical Journal of Basrah University, 2008
- Early onset of breast cancer in a group of British black womenBritish Journal of Cancer, 2008
- Young breast cancer patients in the developing world: incidence, choice of surgical treatment and genetic factorsSouth African Family Practice, 2007
- Immunohistochemical labelling for prostate–specific antigen in breast carcinomasBreast Cancer Research and Treatment, 1999
- Prostate-specific antigen in the breastEndocrine-Related Cancer, 1998
- NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGENUrologic Clinics of North America, 1997
- Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSABritish Journal of Cancer, 1997
- Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancerUrology, 1996